XML 32 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2019
Stockholders' Equity  
Schedule of share-based compensation expense recognized

The estimated grant‑date fair value of the Company’s share‑based awards is amortized on a straight-line basis over the awards’ service periods. Share‑based compensation expense recognized was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2019

    

2018

    

2017

Research and development

 

$

825

 

$

1,077

 

$

1,954

General and administrative

 

 

2,407

 

 

3,290

 

 

4,433

Total stock-based compensation

 

$

3,232

 

$

4,367

 

$

6,387

 

Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

    

 

    

 

 

    

Weighted 

 

 

 

 

 

 

 

Average 

 

 

 

 

Weighted 

 

Remaining 

 

 

 

 

Average 

 

Contractual 

 

 

Number of 

 

Exercise 

 

Term 

 

 

Shares

 

Price

 

(in years)

Balance, December 31, 2017

 

8,624,223

 

$

5.22

 

7.17

Granted

 

4,065,375

 

 

1.70

 

 

Exercised

 

(132,952)

 

 

0.63

 

 

Forfeited/Cancelled

 

(4,291,439)

 

 

(4.38)

 

 

Balance, December 31, 2018

 

8,265,207

 

$

3.99

 

6.99

Granted

 

1,033,000

 

 

1.10

 

 

Exercised

 

(41,968)

 

 

0.68

 

 

Forfeited/Cancelled

 

(1,687,935)

 

 

(4.94)

 

 

Balance, December 31, 2019

 

7,568,304

 

$

3.40

 

7.01

Vested or expected to vest at December 31, 2019

 

7,568,304

 

$

3.40

 

7.01

Exercisable at December 31, 2019

 

4,259,251

 

$

4.24

 

5.92

 

Schedule of weighted-average assumptions:

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

 

    

2019

    

2018

    

2017

 

Expected term of options (in years)

 

6.1

 

5.8

 

6.2

 

Risk-free interest rate

 

1.9

%  

2.8

%  

2.0

%

Expected volatility

 

98.9

%  

71.7

%  

75.6

%

Dividend yield

 

 —

%  

 —

%  

 —

%

 

Schedule of changes in the status of non-vested RSU

 

 

 

 

 

 

 

    

 

    

 

 

 

 

 

 

Weighted 

 

 

 

 

Average 

 

 

Number of 

 

Grant Date

 

 

Awards

 

Fair Value

Non-vested at December 31, 2017

 

 —

 

$

 —

Granted

 

1,255,000

 

 

0.65

Exercised

 

 —

 

 

 —

Forfeited/Cancelled

 

 —

 

 

 —

Non-vested at December 31, 2018

 

1,255,000

 

$

0.65

Granted

 

2,500,585

 

 

0.74

Vested

 

(572,500)

 

 

0.65

Forfeited

 

(237,500)

 

 

0.65

Non-vested at December 31, 2019

 

2,945,585

 

$

0.73

 

Schedule of shares available to be granted under equity incentive plans

At December 31, 2019, the Company has the following shares available to be granted:

 

 

 

 

 

 

    

 

    

Inducement 

 

 

2013 Plan

 

Plan

Available at December 31, 2018

 

2,603,983

 

144,125

Authorized

 

3,459,343

 

 —

Granted

 

(3,533,585)

 

 —

Forfeited/Cancelled

 

1,864,560

 

60,875

Available at December 31, 2019

 

4,394,301

 

205,000

 

Schedule of shares of common stock reserved/available

At December 31, 2019, the Company has reserved the following shares of common stock for issuance:

 

 

 

Stock options outstanding under 2013 Plan

    

7,273,304

Restricted stock units outstanding under 2013 Plan

 

2,945,585

Shares reserved for future issuance under 2013 Plan

 

4,394,301

Stock options outstanding under Inducement Plan

 

295,000

Shares reserved for future issuance under Inducement Plan

 

205,000

Shares reserved for future issuance under 2013 Employee Stock Purchase Plan

 

225,806

Warrants outstanding

 

623,091

Total shares of common stock reserved for future issuance

 

15,962,087